Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study

Table 4

Drug-related adverse events in each group.

Adverse events	Metformin		Pioglitazone + metformin
	Frequency	Rate	Frequency	Rate
Diarrhea	10	100%	3	60%
Urinary occult blood	0	0	1	20%
Cardiovascular abnormalities	0	0	1	20%
Total	10		5